Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.
about
Recent advances in the understanding of antibiotic resistance in Clostridium difficile infectionAntimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile InfectionDiversity and Evolution in the Genome of Clostridium difficileAlterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.Discrimination of Enterobacteriaceae and Non-fermenting Gram Negative Bacilli by MALDI-TOF Mass SpectrometryCharacterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in TaiwanMolecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.Different Resistance Mechanisms for Cadazolid and Linezolid in Clostridium difficile Found by Whole-Genome Sequencing Analysis.gyrA and gyrB mutations are implicated in cross-resistance to Ciprofloxacin and moxifloxacin in Clostridium difficile.In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.Fluoroquinolone resistance does not impose a cost on the fitness of Clostridium difficile in vitro.Fluoroquinolone resistance and Clostridium difficile, Germany.Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998.Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.
P2860
Q26767079-2E9BEE82-700D-4AB5-84A1-33658798FA8BQ28084026-6DC6793E-18E8-4829-804E-7BBFAB7FD9C1Q28084700-8DC93E79-21F4-49A7-9B11-1495295EF39BQ33805682-B33127AB-70EC-4147-8F40-8C4E41D2FCA4Q34898055-0B1AA7E1-A866-438F-84AE-5D2811D974E9Q36086377-246CC0F6-C475-4CB4-A4F1-79A046C248CFQ37204206-2D758A01-9A6E-4C93-8658-81851CBE8269Q38742114-6854E37F-08EF-4B6E-BF26-F6366B5E26CEQ39657922-E03E96BF-4A35-451F-B820-6CA6AB174C6BQ40130484-E3D325D3-809F-4902-B7DF-AB2BBA467D43Q41585335-9074AFC4-48FC-4F56-8816-C644AD49610FQ41983841-E32308E8-2C02-4DD2-89A4-07E9E93EB362Q42116391-77FE39C3-8F5D-476F-99FB-A78A5E4EB5DBQ42676032-5138A906-75D6-441F-80DF-D26D47A32DECQ46448556-185B4413-28A2-4975-AEA8-AEA15D3A5FB1Q53692769-1BD7BF2B-8ADB-45E5-BB81-DFDFF4D3D59C
P2860
Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@en
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@nl
type
label
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@en
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@nl
prefLabel
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@en
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@nl
P2093
P2860
P1476
Resistance to moxifloxacin in ...... ciated with mutations in gyrA.
@en
P2093
A C Rodloff
G Ackermann
P2860
P304
P356
10.1128/AAC.45.8.2348-2353.2001
P407
P577
2001-08-01T00:00:00Z